Evaluation of Residual Symptoms and Anxiety Among Patients on Therapy for Benign Prostatic Hyperplasia at a Nigerian Tertiary Healthcare Facility

    January 2026 in “ Journal of Pharmacy & Bioresources ”
    Florence N. Adule, Jeffrey S Soni, Paul O. Onah
    Studysummary This study found that 44.3% of patients with benign prostatic hyperplasia experienced high anxiety levels, which were significantly associated with residual symptoms and demographic factors.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ajol.info →
    Discuss this study in the Community →